Essential Biomaterials Science

Essential Biomaterials Science

Volumn , Issue , 2014, Pages 1-640

  Williams, David ^{a,b,c,d,e,f,g,h,i,j,k}  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Tissue Engineering and Regenerative Medicine International Society   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g TSINGHUA UNIVERSITY   (China)

^h BEIHANG UNIVERSITY   (China)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^k ROYAL ACADEMY OF ENGINEERING   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85142080912     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139026086     Document Type: Book

References (356)

1. Ducheyne P, Healey K E, Hutmacher D, Grainger D E, Kirkpatrick C J (eds.) Comprehensive Biomaterials, Elsevier, Amsterdam, 2012. Six-volume, 4000-page reference work on biomaterials.
2. Huebsch N, Mooney D J, Inspiration and application in the evolution of biomaterials, Nature 2009;462:426-32. Insightful article on the increasing sophistication of biomaterials.
3. Park J, Lakes R S, Biomaterials: An Introduction, Springer, New York, 3rd edition, 2007. Basic level textbook.
4. Ratner B D, Hoffman AJ, Schoen F J, Lemons J E (eds.) Biomaterials Science: An Introduction to Materials in Medicine, Elsevier, Amsterdam, 3rd edition, 2012. Multi-author collection of reviews and technical chapters covering biomaterials and their applications
5. Temenoff J S, Mikos AG, Biomaterials: The Intersection of Biology and Materials Science, Prentice-Hall, 2008.
6. Williams D F, On the nature of biomaterials, Biomaterials 2009; 30:5897-909. Essay on the changing concepts, scope and applications of biomaterials.
7. Biomaterials, www.journals.elsevier.com/biomaterials/
8. Acta Biomaterialia, www.journals.elsevier.com/actabiomaterialia/
9. Nature Materials, www.nature.com/nmat/
10. Advanced Materials, http://onlinelibrary.wiley.com/ journal/10.1002/ (ISSN)1521-4095
11. Biomacromolecules, http://pubs.acs.org/journal/bomaf6/
12. Journal of Biomedical Materials Research, Part A, http://onlinelibrary.wiley.com/journal/10.1002/ (ISSN) 1552-4965.
13. Behl M, Lendlein A, Shape memory polymers, Materials Today 2007; 10:20-5. Discussion of the concepts and mechanisms of shape memory polymeric materials.
14. Bettinger C J, Synthesis and microfabrication of biomaterials for soft tissue engineering, Pure and Applied Chemistry 2009;81:2183-2201. Review of methods for biomaterials synthesis and biomaterials system design for tissue engineering scaffolds.
15. Borden MA, Zhang H, Gillies R J, Dayton P A, Ferrara K W, A stimulus-responsive contrast agent for ultrasound molecular imaging, Biomaterials 2008;29:597-606. Discussion of the development of stimulus-responsive microbubbles for highly specific molecular imaging.
16. Chu P K, Chen J Y, Wang L P, Huang N, Plasma-surface modification of biomaterials, Materials Science and Engineering R 2002;36:143-206. Very detailed description of plasma surface modification techniques and applications to biomaterials.
17. Falconnet D, Csucs G, Grandin H M, Textor M, Surface engineering approaches to micropattern surfaces for cell-based assays, Biomaterials 2006;27:3044-63. Review of biologically motivated micropatterning of two-dimensional surfaces.
18. Garcia AJ, Interfaces to control cell-biomaterial adhesive interactions, Advances in Polymer Science 2006;203:171-90. Discussion of the mechanisms by which cells attach to biomaterials surfaces.
19. Gentile F, Tirinato L, Battista E, et al., Cells preferentially grow on rough substrates, Biomaterials 2010;31:7205-12. An essay on the control of cell behavior by surface nanotopography.
20. Hao R, Xing R, Xu Z, et al., Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles, Advanced Materials 2010;22: 2729-42. Summary of the strategies to nanoparticle fabrication and functionalization
21. Hummel R E, Electronic Properties of Materials, Springer, New York, 2001. Major textbook on electronic and physical properties of materials.
22. Hummel R E, Understanding Materials Science, Springer New York, 2nd edition, 2004. Introduction to the principles of materials science.
23. Khademhosseini A, Bettinger C, Karp J M, et al., Interplay of biomaterials and micro-scale technologies for advancing biomedical applications, Journal of Biomaterials Science - Polymer Edition 2006;17:1221-40. Overview of the merger of micro-scale technologies and biomaterials in two-dimensional surface patterning, device fabrication and three-dimensional tissue-engineering applications.
24. Liu R, Fraylich M, Saunders B R, Thermoresponsive copolymers: from fundamental studies to applications, Colloid and Polymer Science 2009; 287:627-43. Extensive review of thermally triggered conformational changes in polymers.
25. Lutholf MP, Hubbell J A, Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering, Nature Biotechnology 2005;23:47-55. Explanation of the way in which symbiosis of materials engineering and cell biology may ultimately result in synthetic materials that contain the signals to recapitulate developmental processes in tissue- and organ-specific differentiat ion and morphogenesis.
26. Ma E, Xu, J, The glass window of opportunities, Nature Materials 2009;8:855-7. Short review of the properties of metallic glasses.
27. Ma P X, Biomimetic materials for tissue engineering, Advanced Drug Delivery Reviews 2008;60:184-98. Review of biomimetic approaches to tissue engineering scaffolds and methods to produce nanofibrous materials.
28. Mano J F, Stimuli-responsive polymeric systems for biomedical applications, Advanced Engineering Materials 2008;10:515-27. Review of polymers and polymer surfaces that can reversibly alter their physico-chemical characteristics in response to environmental factors.
29. Merrett K, Cornelius R M, McClung WG, Unsworth L D, Sheardown H, Surface analysis methods for characterizing polymeric biomaterials, Journal of Biomaterials Science - Polymer Edition 2002;13:593-621. Detailed review of methods available to analysis the surface properties of polymeric biomaterials.
30. Mitragotri S, Lahann J, Physical approaches to biomaterial design, Nature Materials 2008;8: 15-23. Discussion of the role of the physical properties of materials in the regulation of biological performance.
31. Moses J E, Moorhouse AD, The growing applications of click chemistry, Chemical Society Reviews 2007;36:1249- 62. Tutorial review of the click chemistry approach to the assembly of new molecular entities.
32. Nguyen MK, Lee D S, Injectable biodegradable hydrogels, Macromolecular Bioscience 2010;10:563-79. Discussion about the requirements of injectable biomaterials and the options currently available.
33. Park J-W, Kim H, Han M, Polymeric self-assembled monolayers derived from surface-active copolymers: a modular approach to functionalized surfaces, Chemical Society Reviews 2010;39:2935-47. A discussion of the design principles for selfassembled monolayers and the resulting chemical and morphological structures.
34. Pelton AR, Russell S M, DiCello J, The physical metallurgy of Nitinol for medical applications. JOM: Journal of Minerals, Metals and Materials Society 2003;55: 33-7. Review of processes and properties that relate to shape memory alloys and their medical applications.
35. Petersen L K, Narasimhan B, Combinatorial design of biomaterials for drug delivery: opportunities and challenges, Expert Opinion on Drug Delivery 2008;5:837-46. Review of the concept of combinatorial chemistry and its application to polymeric biomaterials design.
36. Pinaud F, Michalet X, Bentolila L A, et al., Advances in fluorescence imaging with quantum dot probes, Biomaterials 2006;27:1679-87, Essay on the potential for quantum dot technology in fluorescence imaging.
37. Ratner B D, Hoffman AJ, Schoen F J, Lemons J E (eds.) Biomaterials Science: An Introduction to Materials in Medicine, Elsevier, Amsterdam, 3rd edn, 2012. Major multi-editor, multi-author book that covers the science and clinical applications of biomaterials.
38. Roy D, Brooks WL A, Sumerlin B S, New directions in thermoresponsive polymers, Chemical Society Reviews 2013;42:7214-43. Review of strategies to develop thermoresponsive polymers.
39. Simms HM, Bowman C M, Anseth K S, Using living radical polymerization to enable facile incorporation of materials in microfluidics cell culture devices, Biomaterials 2008;29:2228-36. Description of contact lithographic photopolymerization techniques for preparation of surfaces for high throughput screening applications.
40. Sjollema J, Sharma P K, Dijkstra R J B, et al., The potential for bio-optical imaging of biomaterial-associated infection in vivo, Biomaterials 2010;31:1984-95. Review of bioluminescence and luminescence imaging technologies, especially as applied to biomaterials-related infections.
41. Smallman R E, Ngan AH W, Physical Metallurgy and Advanced Materials, Butterworth-Heineman, New York, 2007. Major textbook on structure and properties of advanced materials.
42. Somorjai G S, Li Y, Impact of surface chemistry, Proceedings of the National Academy of Sciences 2011;108:917-24. Essay on surface chemistry at the molecular level and its relevance to medical technology.
43. Sperling L H, Introduction to Physical Polymer Engineering, John Wiley, New Jersey, 2006. Major textbook dealing with the engineering of polymer systems.
44. Stupp S I, Self assembly and biomaterials, Nano Letters 2010;10:4783-6. Brief perspective on the role of self-assembled materials, especially those based on peptide amphiphiles, in medical technology.
45. Uskokovic V, Challenges for the modern science in its descent towards nano-scale, Current Nanoscience 2009;5:1-18. Extensive discussion of the challenges with nanotechnologies and nanostructured materials.
46. Wang Y-X, Robertson J L, Spillman WB, Claus R O, Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility, Pharmaceutical Research 2004;21:1362-73. Discussion of the ways in which surface structure and properties affect the performance of biomaterials.
47. Williams D F, On the nature of biomaterials, Biomaterials 2009;30:5897-909. Essay on the radical changes in the concepts of biomaterials and their practical applications.
48. Williams D F, The scientific basis for regulating nanotechnologies, in Hodge G S, Bowman D M, Maynard AD, International Handbook on Regulating Nanotechnologies, Edward Elgar, Cheltenham, 2010:107-23. An explanation of the principles of risk assessment with nanoparticles and presentation of a series of nanotechnology definitions.
49. Allori AC, Sailon AM, Warren S M, Biological basis of bone formation, remodeling and repair - part 1: Biochemical signaling molecules, Tissue Engineering 2008;14:259-69. Review of signaling molecules that contribute to the biochemical system associated with bone healing.
50. Anderson J M, Rodriguez A, Chang D T, Foreign body reaction to biomaterials, Seminars in Immunology 2008;20:86-100. Discussion of some classical concepts of the development of the host response to biomaterials.
51. Badylak S F, The extracellular matrix as a biologic scaffold material, Biomaterials 2007;28:3587-93. Opinion paper on the potential and limitations of ECM-derived materials in therapeutic applications.
52. Barton GM, A calculated response: control of inflammation by the innate immune system, Journal of Clinical Investigation 2008;118:413-20. An overview of innate responses to microbial and non-microbial tissue damage and the interplay between innate immunity and inflammation.
53. Bavry AA, Bhatt D L, Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis, Lancet 2008;371: 2134-43. A discussion of the evidence concerning the biological responses to drug-eluting stents.
54. Brown B N, Valentin J E, Stewart-Akers AM, McCabe GP, Badylak S F, Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component, Biomaterials 2009;30:1482-91. Explanation of the polarization of macrophage phenotype induced by biologic scaffolds.
55. Caplan MR, Shah MM, Translating biomaterial properties to intracellular signaling, Cell Biochemistry and Biophysics 2009;54:1-10. A review of the manner in which materials can influence cell behavior through cell-surface interactions and variations in cell signaling phenomena.
56. Chen F-M, Zhang M, Wu Z-F, Toward delivery of multiple growth factors in tissue engineering, Biomaterials 2010;31:6279-308. Review of the concept of growth factor delivery in tissue engineering and the methods to achieve this delivery.
57. Chiquet M, Renedo AS, Huber F, Fluck M, How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biology 2003;22:73-80. Review of mechanotransduction processes in fibroblasts.
58. Chiu J-J, Chien S, Effects of disturbed flow on vascular endothelium: pathophysiology basis and clinical perspectives, Physiological Review 2011; 91:327-87. Extensive review of the mechanisms by which mechanical forces involved within blood flow disturbances affect the endothelium.
59. Chowdhury F, Na S, Li D, et al., Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stem cells, Nature Materials 2010;9:82-8. Explanation of theories of the effect of mechanical stress on gene expression in stem cell differentiation.
60. Coussens L M, Werb Z, Inflammation and cancer, Nature 2002; 420:860-7. New insights into the way in which inflammatory cells orchestrate the tumor microenvironment.
61. Dalby MJ, Topographically induced direct cell mechanotransduction, Medical Engineering & Physics 2005;27:730-42. Review of the influence of topographical features on mechanisms of mechanotransduction.
62. De Jong WH, Borm P J A, Drug delivery and nanoparticles: applications and hazards, International Journal of Nanomedicine 2008;3:133-49. An overview of mechanisms of toxicity with nanoparticles used in drug delivery.
63. Dobrovolskaia MA, McNeil S E, Immunological properties of engineered nanomaterials, Nature Nanotechnology 2007;2:469-78. Review of immunotoxicity of nanoparticles including antigenicity, adjuvants and inflammation.
64. Eckes B, Zigrino P, Kessler D, et al., Fibroblast-matrix interactions in wound healing and fibrosis, Matrix Biology 2000;19:325-32.
65. Elmore S, Apoptosis; a review of programmed cell death, Toxicologic Pathology 2007;35:45-516. A review of mechanisms of apoptosis, including the role of chemicals in the initiation of the intrinsic pathway of apoptosis.
66. Franz S, Rammelt S, Scharnweber D, Simon J C, Immune responses to implants - a review of the implications for the design of immuomodulatory biomaterials, Biomaterials 2011;32:6692-709. Review of mechanisms of the immune response to biomaterials and a discussion of strategies aimed at triggering appropriate responses.
67. Glassman S D, Howard J M, Sweet A, Carreon L Y, Complications and concerns with osteobiologics for spine fusion in clinical practice, Spine 2010;35:1621-8. Discussion of the potential complications associated with the use of active agents such as BMPs in the spine.
68. Gorbet MB, Sefton MV, Biomaterials-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes, Biomaterials 2004;25:5681-703. Review of the role of interactions between proteins and cells in thrombosis.
69. Helming L, Gordon S, Molecular mediators of macrophage fusion, Trends in Cell Biology 2009;19:514-22. Review of the mechanisms of giant cell formation and the related signaling processes.
70. Holst J, Watson S, Lord MS, et al., Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells, Nature Biotechnology 2010;28:1123-9. Demonstration of the role of substrate elasticity, provided by tropoelastin, on stem cell expansion.
71. Hori K, Matsumoto S, Bacterial adhesion; from mechanism to control, Biochemical Engineering Journal 2010; 48:424-34. Review of physicochemical models of bacterial adhesion and potential mechanisms for the control of biofilm formation and cell adhesion.
72. Human P, Zilla P, Characterization of the immune response to valve bioprostheses and its role in primary tissue failure, Annals of Thoracic Surgery 2001;71:S385-8. Experimental observations on the role of the immune response to bioprosthetic valves.
73. Ingham E, Fisher J, The role of macrophages in osteolysis of total joint replacement, Biomaterials 2005;26: 1271-86. Review of the relationships between wear particles, macrophages and osteolysis.
74. Khan W, Farah S, Domb AJ, Drug eluting stents: developments and current status, Journal of Controlled Release 2012; 161:703-12. Review of stents used for coronary artery disease management.
75. Kloxin AM, Benton J S, Anseth K S, In situ elasticity modulation with dynamic substrates to direct phenotype, Biomaterials 2010;31:1-8. Discussion of the effects of microenvironment elasticity on critical cell functions.
76. Kroemer G, Galluzzi L, Vandenabeele P, et al., Classification of cell death, Cell Death and Differentiation 2009; 16:3-11. Recommendations of the Nomenclature Committee on Cell Death on the criteria for definitions of cell death.
77. Le Guehennec L, Soueidan A, Layrolle P, Amouriq Y, Surface treatment of titanium dental implants for rapid osseointegration, Dental Materials 2007;23: 844-54. Explanation of the potential for different surface treatments to control the speed and quality of osseointegration.
78. Liu G, Beri R, Mueller A, Kamp D W, Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis, Chemico-Biological Interactions 2010;188:309-18. Discussion of asbestos-induced apoptosis, oxidative stress and mitochondrial dysfunction.
79. Mallander V, Landfester K, Interaction of nanoparticles with cells, Biomacromolecules 2009;10:2379-400. Review of uptake of nanoparticles by cells and mechanisms of intracellular effects.
80. Martino S, D’Angelo F, Armentano I, Kenny J M, Orlacchio A, Stem cell-biomaterial interactions for regenerative medicine, Biotechnology Advances 2012;30:338-51. Review paper that discusses the translation of stem cell biology into therapeutic applications.
81. Maurer-Jones MA, Bantz K C, Love S A, Marquis B J, Haynes C L, Toxicity of therapeutic nanoparticles, Nanomedicine 2009;4:219-41. Introduction to the applications of therapeutic nanoparticles, their potential toxicity and methods of evaluation.
82. Mazzoli-Rocha F, Fernandes S, Einiker-Lamas M, Zin WA, Roles of oxidative stress in signaling and inflammation induced by particulate matter, Cell Biology and Toxicology 2010;26:481-98. Description of reactive oxygen species and their potential role in the host response to particulate materials.
83. McBride S H, Falls T, Knothe Tate ML, Modulation of stem cell shape and fate; Mechanical modulation of cell shape and gene expression, Tissue Engineering A 2008;14:1573-80. Detailed analysis of the role of the mechanical environment on stem cell condensation.
84. Mei Y, Saha K, Bogatyrev S R, et al., Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells, Nature Materials 2010;9:768-78. A description of structure-function analysis for stem cell activity on polymer surfaces.
85. Moller P, Jacobsen NR, Folkmann J K, et al., Role of oxidative damage in toxicity of particulates, Free Radical Research 2010;44:1-46. Very detailed analysis of the evidence concerning reactive oxygen species and their role in the toxicology of particles.
86. Monopoli MP, Aberg C, Salvati, Dawson K A, Biomolecular coronas provide the biological identity of nanosized materials, Nature Nanotechnology 2012;7:779-86. A critical assessment of the role of the nanoparticle corona in determining the particle fate.
87. Montanaro L, Campoccia D, Arciola C R, Advancements in molecular epidemiology of implant infections and future perspectives, Biomaterials 2007;28:5155-68. Review of the application of molecular epidemiological techniques to the analysis of bacterial adhesion and colonization of biomaterial surfaces.
88. Murata H, Koepsel R R, Matyjaszewski K, Russell AJ, Permanent non-leaching antibacterial cells - 2: How high density cationic surfaces kill bacterial cells, Biomaterials 2007;28:4870-9. Description of polymer brushes that can be tuned for bacterial killing while attached to biomaterial surfaces.
89. Nel A E, Madler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface, Nature Materials 2009;8:543-57. Review of the interactions between cells and nanoparticles, especially in relation to the dynamic forces and molecular interactions that are involved.
90. Orr AW, Helmke B P, Blackman B R, Schwartz MA, Mechanisms of mechanotransduction, Developmental Cell 2006;10:11-20. Review of specific mechanisms that control the effects of mechanical cues on cells.
91. Park S-J, Kang S-J, Virmani R, Nakano M, Ueda Y, In-stent restenosis: a final common pathway of late stent failures, Journal of the American College of Cardiology 2012;59:2051-7. A well-illustrated discussion of the pathology of in-stent restenosis.
92. Ploux L, Ponche A, Anselme K, Bacteria/material interfaces: role of the material and cell wall properties, Journal of Adhesion Science and Technology 2010;24:2165- 201. Description of the development of biofilms and the mechanisms of bacterial adhesion.
93. Pollard K M, Hultman P, Kono D H, Toxicology of autoimmune disease, Chemistry Research Toxicology 2010;23:455-66. Discussion of mechanisms of autoimmune disease with an emphasis on the effects of extrinsic factors such as exposure to materials and chemicals
94. Rogers T H, Babensee J E, The role of integrins in the recognition and response of dendritic cells to biomaterials, Biomaterials 2011;32:1270-9. Experimental demonstration of the role of biomaterials surfaces in dendritic maturation on initiation of adaptive immunity processes.
95. Sahay G, Alakhova D Y, Kabanov AV, Endocytosis of nanomedicines, Journal of Controlled Release 2010;145:182-95. Review of mechanisms of endocytosis and variables which influence cell entry by nanoparticles.
96. Shukla A, Fleming K E, Chuang HF, et al., Controlling the release of peptide antimicrobial agents from surfaces, Biomaterials 2010;31:2348-57. Description of antimicrobial peptides and their mechanism of activity against antibiotic-resistant bacteria.
97. Singh N, Manshian B, Jenkins G J S, et al. NanoGenotoxicology: the DNA damaging potential of engineered nanoparticles, Biomaterials 2009;30:3891-914. A review of the genotoxic potential of engineered nanomaterials and methods of risk assessment.
98. Tesfamariam B, Local vascular toxicokinetics of stent-based drug delivery, Toxicology Letters 2007;168:93-102. A review of the relationship between local drug delivery from stents and the release profile.
99. Varkouhi AK, Scholte M, Storm G, Haisma H J, Endosomal escape pathways for delivery of biologicals, Journal of Controlled Release 2011;151:220-8. Review of mechanisms by which substances escape from endosomes within the endocytic pathway.
100. Vogler E A, Siedlecki C A, Contact activation of blood-plasma coagulation, Biomaterials 2009;30:1857-69. Essay on the biochemical mechanisms of contact activation of blood-plasma coagulation.
101. Wilson C J, Clegg R E, Leavesley D I, Pearcy MJ, Mediation of biomaterial-cell interactions by adsorbed proteins; a review, Tissue Engineering 2005;11:1-18. Discussion of the pivotal role of extracellular adhesion proteins in cell adhesion, morphology and migration.
102. Wu P, Grainger D W, Drug/device combinations for local drug therapies and infection prophylaxis, Biomaterials 2006;27:2450-67. Review of combination devices, including interactions between material and drug components.
103. Wu X, Cheng J, Li P, et al., Mechano-sensitive transcriptional factor Egr-1 regulates insulin-like growth factor-1 receptor expression and contributes to neointima formation in vein grafts. Arteriosclerosis, Thrombosis and Vascular Biology 2010;30:471-6.
104. Zilla P, Bezuidenhout D, Human P, Prosthetic vascular grafts: wrong models, wrong questions and no healing, Biomaterials 2007;28:5009-27. Critical appraisal of the biocompatibility and performance of vascular grafts.
105. Bohsall K I, Wirth MA, Rockwood C A, Complications of total shoulder arthroplasty, Journal of Bone and Joint Surgery 2006;88A:2279-90. Discussion of clinical experiences and outcomes of total shoulder prostheses.
106. Browne J A, Bechtold C D, Berry D J, Hanssen AD, Lewallen D G, Failed metal-on-metal hip arthroplasties, Clinical Orthopedics and Related Research 2010;468:2313-20. Analysis of failure mechanisms of metal-on-metal hips.
107. Chen J, Xu J, Wang A, Zheng M, Scaffolds for tendon and ligament repair: review of the efficacy of commercial products, Expert Reviews of Medical Devices 2009;6:61-73. A review of devices and relevant clinical trials associated with tendon and ligament repair.
108. Gamradt S C, Wang J C, Lumbar disc arthroplasty, The Spine Journal 2005;5:95-103. Discussion of features that control the success of total disc arthroplasty.
109. Goins ML, Wimberley D W, Yuan P S, Fitzhenry L N, Vaccaro AR, Nucleus pulposis replacement: an emerging technology, The Spine Journal 2005;5:317S-24S. Description of surgical methods to relieve recalcitrant symptoms of disc degeneration using partial removal of the disc.
110. Hailer NP, Garellick G, Karrholm J, Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register: evaluation of 170,413 operations, Acta Orthopaedica 2010;81:34-41. Major review of the outcomes of total hip replacement procedures.
111. Heisel C, Kinkel S, Bernd L, Ewerbeck V, Megaprostheses for the treatment of malignant bone tumours of the lower limb, International Orthopedics 2006;30:452-7. Discussion of prostheses used in reconstruction of the lower limb after cancer surgery.
112. Hosman AH, Mason R B, Hobbs T, Rothwell AG, A New Zealand national joint registry review of 202 total ankle replacements followed for 6 years, Acta Orthopaedica 2007;78:584-91. Detailed review of outcomes of total ankle replacement.
113. Lee K, Goodman S B, Current state and future of joint replacements in the hip and knee, Expert Reviews in Medical Devices 2008;5:383-93. Review of the performance of hip and knee replacement surgery.
114. Morshed S, Bozic K J, Ries MD, Malchau H, Colford J M, Comparison of cemented and uncemented fixation of total hip replacement, Acta Orthopaedica 2007;78:315-26. Detailed analysis of the outcomes of cemented and uncemented hip procedures.
115. Prosser G H, Yates P J, Wood D A, et al., Outcome of primary resurfacing hip replacement: evaluation of risk factors for early revision in 1203 replacements from the Australian Joint Registry, Acta Orthopaedica 2010;81:66-71. Review of risk factors in metal-on-metal hip procedures as revealed by analysis of registry data.
116. Rahaman MN, Yao A, Bal B S, Garino J P, Ries MD, Ceramics for prosthetic hip and knee replacement, Journal of the American Ceramics Society. 2007;40:1965-88. Review of the use of ceramics in total joint replacement.
117. Van den Eerenbeemt K D, Ostelo R W, van Royen B J, Peul WC, van Tulder MW, Total disc replacement surgery for symptomatic degenerative lumbar disc disease: a systematic review of the literature, European Spine Journal 2010;19:1262-80. An evaluation of the effectiveness and safety of total disc replacement surgery, with comparison to spinal fusion.
118. Ziran B H, Smith WR, Anglen J O, Tournetall P, External Fixation: how to make it work, Journal of Bone and Joint Surgery 2007;89A:1620-32. Instructional lecture on the principles and practices of external fixation.
119. Zywiel MG, Sayeed S A, Johnson AJ, Schmalzried T P, Mont MA, Survival of hard-on-hard bearings in total hip arthroplasty, Clinical Orthopedics and Related Research 2011;469:1536-46. A systematic review of the performance of metal-on-metal and ceramic-on-ceramic hip replacements.
120. Borek P P, Wilkoff B L, Pacemaker and ICD leads: strategies for long-term management, Journal of Interventional Cardiac Electrophysiology 2008;23:59-72. Review of practical aspects of managing patients with implanted arrhythmia control devices.
121. Carabello B A, Mitral valve repair in the treatment of mitral regurgitation, Current Treatment Options in Cardiovascular Medicine 2009;11:419-25. Describes techniques and outcomes for mitral regurgitation, including repair methods.
122. Coeytaux R R, Williams J W, Gray R N, Wang A, Percutaneous heart valve replacement for aortic stenosis: state of the evidence, Annals of Internal Medicine 2010;153:314-24. Discussion of the outcomes of clinical trials on percutaneous heart valve replacement.
123. Epstein AE, Benefits of the implantable cardioverter-defibrillator, Journal of the American College of Cardiology 2008;52:1122-7. Essay on the advantages and disadvantages of the ICD.
124. Jorapur V, Cano-Gomez A, Condie C A, Should saphenous vein grafts be the conduits of last resort for coronary artery by-pass surgery, Cardiology in Review 2009;17:235-42. A critical analysis of the respective roles of saphenous veins and internal mammary arteries in therapy for coronary artery disease.
125. Kapadia MR, Popowich D A, Kibbe MR, Modified prosthetic vascular conduits, Circulation 2008;117:1873-82. A review of approaches to modify vascular graft materials intended to improve patency rates.
126. Lip G Y H, Tse H-F, Management of atrial fibrillation, The Lancet 2007;370:604-18. An overview of pharmaceutical and non-pharmaceutical approaches to atrial fibrillation.
127. Mahadevan V S, Gomperts N, Haberer K, et al., Transcatheter closure of atrial septal defects with multiple devices in adults: procedure and clinical outcomes, International Journal of Cardiology 2009;133:359-63. Describes the transcatheter technology for the closure of atrial septal defects.
128. Pibarot P, Dumesnil J G, Prosthetic heart valves: selection of the optimal prosthesis and long term management, Circulation 2009;119:1034-49. Review of criteria for heart valve prosthesis selection.
129. Rahimtoola S H, Choice of prosthetic heart valve in adults, Journal of the American College of Cardiology 2010;55:2413-26. Consideration of published data on life-time performance of mechanical and bioprosthetic valves and presentation of an algorithm for valve choice.
130. Rayt HS, Sutton AJ, London NJ M, Sayers R D, Bown MJ, A systematic review and meta-analysis of endovascular repair for ruptured abdominal aortic aneurysm, European Journal of Vascular and Endovascular Surgery. 2008;36:536-44. Review of the literature dealing with outcomes of abdominal aortic aneurysm repair.
131. Schoder M, Lammer J, Czerny M, Endovascular aortic arch repair: hopes and certainties, European Journal of Vascular and Endovascular Surgery 2009; 38:255- 61. Discusses the devices and techniques used in the treatment of aneurysms and dissections of the aortic arch and difficulties with the complex geometry of the area when implanting stent grafts.
132. Schoen F J, Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology and tissue engineering, Circulation 2008;118:1864-80. Discussion of the role of valve dynamics on repair and regeneration philosophies.
133. Schoen F J, Levy R J, Tissue heart valves: current challenges and future research perspectives, Journal of Biomedical Materials Research 1999;47:439-65. Detailed perspective on the future of tissue heart valves - a little old but still valid.
134. Schoen F J, Levy R J, Calcification of tissue heart valve substitutes: progress towards understanding and prevention. Annals of Thoracic Surgery 2005;79:1072-80. A description of the mechanisms of heart valve leaflet calcification.
135. Tung R, Zimetbaum P, Josephson ME, A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death, Journal of the American College of Cardiology 2008;52:1111-21. Analysis of the advantages and disadvantages of the ICD.
136. Wilson S R, Givertz MM, Stewart G C, Mudge GH, Ventricular assist devices, Journal of the American College of Cardiology 2009;54:1647-59. A review of the devices available for mechanical assistance of the failing heart, their performance and the management of patients.
137. Yasuda S, Shimokawa H, Acute myocardial infarction: the enduring challenge for cardiac protection and survival, Circulation Journal 2009; 73:2000-8. Essay on the therapies available for the treatment of myocardial infarction.
138. Zarins C K, Arko F R, Crabtree T, et al., Explant analysis of AneuRx stent grafts: relationship between structural findings and clinical outcome, Journal of Vascular Surgery 2004; 40:1-11. Discussion of the performance of stent grafts and their dependence on materials and designs.
139. Cengiz E, Sherr J L, Weinzimer S A, Tamborlane WV, New generation diabetes management: glucose sensor augmented insulin pump therapy, Expert Review of Medical Devices 2011;8:449-58. Perspective on the future technologies for insulin pumps.
140. Humes HD, Fissell WH, Tiranathanagul K, The future of hemodialysis membranes, Kidney International 2006;69:1115-19. Essay of the future developments for hemodialysis.
141. Backous D D, Duke W, Implantable middle ear hearing devices: current state of technology and market challenges, Current Opinion in Otolaryngology and Head and Neck Surgery 2006;14:314-18. The technology of devices in the middle ear.
142. McGlinchey S M, McCoy C P, Gorman S P, Jones D S, Key biological issues on contact lens development, Expert Review in Medical Devices 2008;5(5): 581-90. Summary of key developments in contact lenses.
143. Rao K, Ahmed I, Blake D A, Ayyala R S, New devices in glaucoma surgery, Expert Review in Ophthalmology. 2009;4(5):491-504. Review of developments of therapies for glaucoma, especially implantable devices.
144. Renner G. Lane R V. Auricular reconstruction: an update, Current Opinion in Otolaryngology and Head and Neck Surgery. 2004;12:277-80. Review of techniques for ear reconstruction.
145. Walter P, Implants for artificial vision, Expert Review in Ophthalmology. 2009;4(5):515-23. Review of the technologies under development for artificial vision.
146. Werner L, Biocompatibility of intraocular lens materials, Current Opinions in Ophthalmology 2008; 19(1):41-9. Review of the factors that control the host response to intraocular lens materials.
147. Wilson B S, Dorman MF, Cochlear implants: current designs and future possibilities, Journal of Rehabilitation and Restorative Development. 2008;45 (5):695-731. Extensive review of the technology of cochlear implants.
148. Yung M, Vowler S L, Long term results in ossiculoplasty; an analysis of prognostic factors, Otology Neurology 2006;27:874-81. A review of the prognosis of treatment modalities in middle ear surgery.
149. Collins K L, Lehmann E M, Patil P G, Deep brain stimulation for movement disorders, Neurobiology of Disease 2010;38:338-45. Description of indications for deep brain stimulation, the technology and the outcomes.
150. Myllymaa S, Myllymaa K, Lappalainen R, Flexible implantable thin film neural electrodes, Recent Advances in Biomedical Engineering 2009:Ch.9:165-89. Extensive review of microfabrication techniques for recording and stimulating neural electrodes.
151. Zhong Y, Bellamkonda R V, Biomaterials for the central nervous system, Journal of the Royal Society Interface 2008;5:957-75. Review of the requirements for materials placed within the brain.
152. Barroso U, Lordelo P, Electrical nerve stimulation for overactive bladder in children, Nature Reviews Urology 2011;8:402-7. Discussion of the use of electrical nerve stimulation in children with a focus on mechanisms of action and clinical results.
153. Bodiwala D, Summerton D J, Terry T R, Testicular prostheses: development and modern usage, Annals Royal College of Surgeons of England 2007;89:349-53. Review of controversies concerning biomaterials used for testicular prostheses.
154. Kotb AF, Campeau L, Corcos J, Urethral bulking agents: techniques and outcomes, Current Urology Reports 2009;10:396-400. Discussion of bulking agents for women suffering with stress urinary incontinence.
155. Liatsikos E, Kallidonis P, Stolzenburg J-U, Karnabatidis D, Ureteral stents: past, present and future. Expert Reviews in Medical Devices 2009; 6:313-24. Discussion of materials most commonly used for ureteral stents and their complications.
156. McIntyre M, Goudeelocke C, Rovner E S, An update on surgery for pelvic organ prolapse, Current Opinion in Urology 2010;20:490-4. A review of the surgical management of pelvic organ prolapse with a commentary of the benefits and limitations of current techniques.
157. Norton P, Brubaker L, Urinary incontinence in women, Lancet 2006;367:57-67. Seminar type review of causes and treatment of incontinence, including the use of biomaterials and implanted devices.
158. Sandhu J S, Treatment options for male stress urinary incontinence, Nature Reviews in Urology 2010;7:222- 8. Review of options for the management of male stress urinary incontinence, including artificial sphincters, bulking agents and slings.
159. Favretti F, Ashton D, Busetto L, Segato G, De Luca M, The gastric band: first choice procedure for obesity surgery, World Journal of Surgery 2009; 33:2039- 48. Review of the results of laparoscopic adjustable gastric banding and comparison with other techniques of obesity surgery.
160. Benagiano G, Gabelnick H, Farris M, Contraceptive devices: intravaginal and intrauterine delivery systems, Expert Reviews of Medical Devices 2008;5:639-54. Discusses the availability and performance of vaginal rings and intrauterine devices.
161. Ehrenfest DMD, Coelho P G, Kang B-S, Sul Y-T, Albrektsson T, Classification of osseointegrated implant surfaces: materials, chemistry and topography, Trends in Biotechnology 2009;28:198- 206. Discussion of the role of surface features in the mechanism of osseointegration.
162. Neovius E, Engstrand T, Craniofacial reconstruction with bone and biomaterials: review over the last 11 years, Journal of Plastic, Reconstructive and Aesthetic Surgery 2010;63:1615-23. Analysis of the performance of biomaterials and bone grafts in the reconstruction of craniofacial bones in congenital defects.
163. Orentlicher G, Goldsmith D, Horowitz A, Applications of 3-dimensional virtual computerized tomography technology in oral and maxillofacial surgery, Journal of Oral and Maxillofacial Surgery 2010;68:1933-59. Description of technologies for imaging of maxillofacial defects and their reconstruction.
164. Shah J P, Gil Z, Current concepts in management of oral cancer - surgery, Oral Oncology 2009; 45:394-401. A review of the options for the treatment of malignancies of the oral cavity.
165. Binnebosel M, von Trotha K T, Jansen P L, et al., Biocompatibility of prosthetic meshes in abdominal surgery, Seminars in Immunopathology 2011;33:235-43. Review of the factors that control the biocompatibility and clinical performance of meshes used in hernia repair.
166. Spear S L, Jespersen MR, Breast implants: saline or silicone? Aesthetic Surgery Journal 2010;30:557-70. Editorial on the merits of different types of breast implant.
167. Ahmed T A E, Hincke T, Strategies for articular cartilage lesion repair and functional restoration, Tissue Engineering Part B 2010;16:305-29. Review of techniques, from conservative, reparative to regenerative, in treatment of cartilage lesions.
168. Atala A, Bauer S B, Soker S, Yoo J J, Retik A B, Tissue engineered autologous bladders for patients needing cystoplasty, The Lancet 2006;367 (9518): 1241-6. Description of tissue engineering techniques for bladder regeneration.
169. Atala A, Lanza R, Thomson J A, Nerem R, Principles of Regenerative Medicine, Academic Press, London, 2nd edition 2011.
170. Bleiziffer O, Eriksson E, Yao F, Horch R E, Kneser U, Gene transfer strategies in tissue engineering, Journal of Cell and Molecular Medicine 2007; 11:206-23. Review of situations where gene transfer techniques may be used to enhance tissue regeneration.
171. Deumens R, Bozkurt A, Meek M F, et al., Repairing injured peripheral nerves: bridging the gap, Progress in Neurobiology 2010;92:245-76. Discussion of experimental and clinical observations on peripheral nerve repair.
172. Di Maggio N D, Piccinini E, Jaworski M, et al., Toward modeling the bone marrow niche using scaffold-based 3D culture systems, Biomaterials 2011;32:321-9. Discussion of the performance of 3D perfusion culture system that attempts to replicate the bone marrow niche.
173. Discher D E, Mooney D J, Zandstra P, Growth factors, matrices and forces combine to control stem cells, Science 2009;324:1673-7. Essay on the factors that control stem cell behavior within the stem cell niche.
174. George A, Ravindram S, Protein templates for hard tissue engineering, Nano Today 2010;5:254-66. Essay on nanofibrous protein structures used for bone tissue engineering.
175. Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K, Skin tissue engineering in vivo and in vitro applications, Advanced Drug Delivery Reviews 2011; 128:352-66. Review of tissue engineered skin substitutes and relevant biomaterials.
176. Guillotin B, Souquet A, Catros S, et al., Laser assisted bioprinting of engineered tissue with high cell density and microscale organization, Biomaterials 2010;31:725-6. Description of a laser-controlled cell printing process that prints tissue with high cell density and micro-scale organization.
177. Huang G T-J, Induced pluripotent stem cells - a new foundation in medicine. Journal of Experimental and Clinical Medicine 2010;2:202-17. Review of the derivation and characterization of iPScells, and their potential for cell-based therapies.
178. Huang G T-J, Gronthos S, Shi S, Mesenchymal stem cells from dental tissues versus those from other sources, Journal of Dental Research 2009;88:792-808. Detailed discussion of the regenerative potential of MSCs derived from dental tissues.
179. Huh, D, Torisawa Y, Hamilton G A, Kim H J, Ingber D E, Microengineered physiological biomimicry: organs-on-chips, Lab on a Chip 2012;12:2156-64. Review of microfluidic approaches to in vitro organ mimicry for drug testing.
180. Krawiec J T, Vorp D A, Adult stem cell-based tissue engineered blood vessels: a review, Biomaterials 2012; 33:3388-400. Review of the use in bone marrow mononuclear and other stem cells in the development of tissue engineered blood vessels.
181. Laflamme M A, Murry C E, Heart regeneration, Nature 2011;473:326-35. Review of the biology of heart regeneration and the potential therapies for heart failure.
182. Lampe K J, Heilshorn S C, Building stem cell niches from the molecule up through engineered peptide materials, Neuroscience Letters 2012;519:138-46. Review of self-assembled peptide and protein structures used in attempts to replicate the stem cell niche.
183. Lee K, Silva E A, Mooney, D J, Growth factor delivery-based tissue engineering: general approaches and a review of recent developments, Journal of the Royal Society Interface 2011;8:153-70. Overview of the methods for growth factor delivery in tissue engineering.
184. Leong K F, Cheah C M, Chua C K, Solid freeform fabrication of three dimensional scaffolds for engineered replacement of tissues and organs, Biomaterials 2003;24:2363-78. Review of the principles of SFF, with detailed discussion and comparisons of 3D printing, selective laser sintering and fused deposition modeling.
185. Macchiarini P, Jungebluth P, Go T, et al., Clinical transplantation of a tissue engineered airway, The Lancet 2008;372:2023-30. Description of the first clinically successful use of a tissue engineered trachea, derived from decellularized donor tracheal tissue and autologous epithelial cells and chondrocytes.
186. Moeller H-C, Mian M K, Shrivastava S, Ching B G, Khademhosseini A, A microwell array system for stem cell culture, Biomaterials 2008;29:752-63. Detailed description of the design, fabrication and validation of microarray systems for ES cell culture.
187. Nichols J E, Cortiella J, Engineering of a complex organ; progress toward development of a tissue-engineered lung, Proceedings of the American Thoracic Society 2008; 5:723-30. Review of the factors that face the development of a tissue-engineered lung.
188. Norotte C, Marga F S, Niklason L E, Forgacs G, Scaffold-free vascular tissue engineering using bioprinting, Biomaterials 2009; 30:5910-17. Report on a fully biological self-assembly approach to rapid prototyping bioprinting for scaffold-free small diameter vascular reconstruction.
189. Raya-Rivera A, Esquilliano D R E, Yoo J J, et al., Tissue-engineered autologous urethras for patients who needed reconstruction: an observational study, The Lancet 2011;377:1175-82.Discussion of procedures for the preparation and implantation of autologous tissue-engineered urethras used in cases of trauma in pediatric patients.
190. Roh J D, Sawh-Martinez R, Brennan M P, et al., Tissue engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling, Proceedings of the National Academy of Sciences 2010;107:4669-74. Discussion of techniques to produced tissue engineered vascular grafts based on degradable polymer scaffold and bone marrow mononuclear cells.
191. Rosenthal A, Macdonald A, Voldman J, Cell patterning chip for controlling the stem cell microenvironment, Biomaterials 2007;28:3208-16. Description of a microfabricated polymer chip, of thousands of microwells sized to trap down to a single stem cell.
192. Sahni V, Kessler J A, Stem cell therapies for spinal cord injury, Nature Reviews Neurology 2010;6:363-72. Consideration of the pathology of SCI and the role of stem cell therapy in its management.
193. Santoro, R, Olivares A L, Brans G, et al., Bioreactor based engineering of large-scale human cartilage grafts for joint resurfacing, Biomaterials 2010;31:8946-52. Demonstration of techniques to form clinically relevant volumes of cartilage, using chondrocytes, hyaluronic acid scaffolds and perfusion bioreactors.
194. Schoen F J, Heart valve tissue engineering: quo vadis? Current Opinion in Biotechnology 2011;22:698-705. Authoritative opinion on the challenges and future possibilities for pediatric heart valve tissue engineering.
195. Seekine H, Shimizu T, Okano T, Myocardial tissue engineering: towards a bioartificial pump, Cell Tissue Research 2012;347:775-82. Review of technical and clinical aspects of cell sheet engineering in the myocardium.
196. Sill T J, von Recum H A, Electrospinning: applications in drug delivery and tissue engineering, Biomaterials 2008;29: 1989-2006. Comprehensive review of the technology and applications of electrospinning.
197. Takahashi K, Yamanaka S, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell 2006;126:663-76. First description of iPSCs, produced by gene transfer.
198. Turner NJ, Badylak S F, Regeneration of skeletal muscle, Cell and Tissue Research 2012;347:759-74. Excellent review of approach to regeneration of skeletal muscle and therapeutic possibilities.
199. Van Blitterswijk C, Thomsen P, Lindahl A, et al. (eds), Tissue Engineering, Elsevier, Amsterdam 2008.
200. Werbowetski-Ogilvie T E, Bosse M. Stewart M, et al., Characterization of human embryonic stem cells with features of neoplastic progression, Nature Biotechnology 2009;27:91-7. Presentation and discussion of experimental work on teratoma formation following the use of injected ESCs.
201. Woolfson D N, Mahmoud Z N, More than just bare scaffolds; towards multi-component and decorated fibrous biomaterials, Chemical Society Review 2010;39:3464- 79. Discussion of the evolution of fibrous biomaterials scaffolds, especially those based on peptides and with biologically active surfaces.
202. Zhu J, Li J, Wang B, et al., The regulation of phenotype of cultured tenocytes by microgrooved surface structure, Biomaterials 2010;31:6952-8. Description of experiments that confirm the ability to control the phenotype of cells when cultured on surfaces with microgrooves.
203. Blanchette J, Kavimandan N, Peppas NA, Principles of transmucosal delivery of therapeutic agents, Biomedicine and Pharmacotherapy 2004;58:142-51. Discussion of the use of hydrogels to increase the bioavailability of orally administered therapeutic agents.
204. Bugaj AM, Targeted photodynamic therapy - a promising strategy of tumor treatment, Photochemical and Photobiological Sciences 2011;10:1097-1109. Discussion of the principles of PDT and the potential benefits of targeting this treatment modality for cancer.
205. De Koker S, Lambrecht B N, Willart MA, et al., Designing polymeric particles for antigen delivery, Chemical Society Reviews 2011;40:320-39. Detailed analysis of the chemistry of polymers used to enhance vaccine effectiveness.
206. De Vry J, Martinez-Martinez P, Losen M, et al., In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery, Progress in Neurobiology 2010;92:227-44. A discussion of the mechanisms of electroporation and the delivery of DNA into cells.
207. Drulis-Kawa Z, Dorotkiewicz-Jach A, Liposomes as delivery systems for antibiotics, International Journal of Pharmaceutics 2010; 387:187-98. Review of the experimental and clinical work on liposomal antibiotics, including advantages and disadvantages.
208. Duncan R, The dawning era of polymer therapeutics, Nature Reviews Drug Discovery 2003; 2:347-60. The first paper to introduce the concept of polymer therapeutics.
209. Eljarrat-Binstock E, Domb AJ, Iontophoresis: a non-invasive ocular drug delivery, Journal of Controlled Release 2006; 110:479-89. Overview of the approaches to the development of ocular iontophoretic devices.
210. Fredenberg S, Wahlgren M, Reslow M, Axelsson A, The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review, International Journal of Pharmaceutics 2011, 415:34-52. A review of the mechanisms by which PLGA is able to release drugs.
211. Giudice E L, Campbell J D, Needle-free vaccine delivery, Advanced Drug Delivery Reviews 2006;58:68-89. Review of the technologies for and physiological implications of needle-free vaccine delivery.
212. Hubbell J A, Chilkoti A, Nanomaterials for drug delivery, Science 2012;337:303-5. A short review of the principles of nanomedicines.
213. Kohane D S, Microparticles and nanoparticles for drug delivery, Biotechnology and Bioengineering 2007; 96:203-9. An essay on the general principles of particulate drug delivery systems and opportunities for future developments.
214. Krishnamachari Y, Geary S M, Lemke C D, Salem AK, Nanoparticle delivery systems in cancer vaccines, Pharmacological Research 2011;28:215-36. A discussion of the development of cancer vaccines based on nanoparticles.
215. Kulkarni M, Greiser U, O’Brien T, Pandit A, Liposomal gene delivery mediated by tissue-engineered scaffolds, Trends in Biotechnology 2010, 28, 28-36. A review of the mechanisms by which liposomes can deliver genes within tissue engineering scaffolds.
216. Lammers T, Kiessling F, Hennink WE, Storm G, Drug targeting to tumors: principles, pitfalls and pre-clinical progress, Journal of Controlled Release 2012;161:175-87. Significant review of the concepts and reality of targeting chemotherapeutic agents to tumors.
217. Marambio-Jones C, Hoek EMV, A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment, Journal of Nanoparticle Research 2010;12:1531-51. Extensive discussion of the antibacterial activity of nanosilver.
218. Mintzer MA, Simanek E E, Nonviral vectors for gene delivery, Chemical Reviews 2009;109:259-302. An essay on the principles of non-viral delivery systems.
219. Petros R A, DeSimone J M, Strategies in the design of nanoparticles for therapeutic applications, Nature Reviews Drug Discovery 2010;9:615-26. Discusses the reasons why nanoparticles have difficulty in surmounting the biological barriers of drug delivery.
220. Phillips J E, Gersbach C A, Garcia AJ, Virus-based gene therapy strategies for bone regeneration, Biomaterials 2007; 28: 211-29. Discussion of viral vectors in bone tissue engineering.
221. Polat B E, Hart D, Langer R, Blankschtein D, Ultrasound-mediated transdermal drug delivery: mechanisms, scope and emerging trends, Journal of Controlled Release 2011;152:330-48. A review of the use of low and high frequency ultrasound to increase skin penetration of drugs.
222. Pradeep K, Dahl S, Holmes-Farley R, Huval C C, Jozefeak T H, Polymers as drugs, Advances in Polymer Science 2006;192:9-58. Extensive review of the role of polymers in therapeutic systems.
223. Prausnitz MR, Microneedles for transdermal drug delivery, Advanced Drug Delivery Reviews 2004; 56:581-7. Review of uses and mechanisms of microneedles.
224. Prausnitz MR, Langer R, Transdermal drug delivery, Nature Biotechnology 2008; 26:1261-8. A discussion of various technologies for transdermal delivery, including chemical enhancers, ultrasound and iontophoresis, microneedles and electroporation.
225. Ruenraroengsak P, Cook J M, Florence AT, Nanosystem drug targeting: facing up to complex realities, Journal of Controlled Release 2010;141:265-76. Review of the limitations of nanomedicines, including nanoparticle instability and variations in nanoparticle transport and targeting.
226. Sahay G, Alakhova D Y, Kabanov AV, Endocytosis of nanomedicines, Journal of Controlled Release 2010;145:182-95. A review that classifies mechanisms of nanomedicines and discusses the effects of nanoparticle characteristics on these processes.
227. Sawant R R, Torchilin VP, Liposomes as smart pharmaceutical nanocarriers, Soft Matter 2009; 6:4026-44. Discusses the evolution of liposomes, with an emphasis on stimuli-sensitive liposome systems.
228. Singh R, Lillard J W, Nanoparticle-based targeted drug delivery, Experimental and Molecular Pathology 2009; 86:215-23. Review of nanomedicines including the formulations being developed for vaccines, therapeutic proteins and cancer therapeutics.
229. Somia N, Verma I M, Gene therapy: trials and tribulations, Nature Reviews Genetics 2000; 1:91-9. Discussion of serious errors in early gene therapy trials and the lessons learnt.
230. Stachowiak J C, Li T H, Arora A, Mitragotri S, Fletcher D A, Dynamic control of needle-free injection, Journal of Controlled Release 2009;135:104-12. Discussion of the mechanisms of needle-free injections.
231. Stamatialis D F, Papenburg B J, Girones M, et al., Medical applications of membranes: drug delivery, artificial organs and tissue engineering, Journal of Membrane Science 2008;308:1-34. Review of membrane materials in drug delivery.
232. Staples M, Microchips and controlled-release drug reservoirs, WIREs Nanomedicine and Nanobiotechnology 2010;2:400-17. Review of electromechanical devices in drug delivery systems.
233. Xie J, Lee S, Chen X, Nanoparticle-based theranostic agents, Advanced Drug Delivery Reviews 2010;62:1064-79. Introduction to the principles of theranostics.
234. Yoo J-W, Irvine D J, Discher D E, Mitragotri S, Bio-inspired, bioengineered and biomimetic drug delivery carriers, Nature Reviews: Drug Discovery 2011, 10, 521-35. Wide-ranging discussion of the role of biomimetics in drug delivery.
235. Byers R J, Hitchman E R, Quantum dots brighten biological imaging, Progress in Histochemistry and Cytochemistry 2011;45:201-37. Review of the uses of quantum dots in histopathology and in vivo imaging
236. Cao T, Yang Y, Gao Y, et al., High-quality water-soluble and surface functionalized upconversion nanocrystals as luminescent probes for bioimaging, Biomaterials 2011;32:2959-68. Discussion of the use of functionalization of upconversion luminescent nanoparticles.
237. Chatterjee D K, Gnanasammandhan MK, Zhang Y, Small upconverting fluorescent nanoparticles for biomedical applications, Small 2010; 24:2781-95. Introduction to upconverting fluorescent nanoparticles, their surface modification and functionalization and their prospects for biomedical imaging applications.
238. Chen H, Jiang C, Yu, C, et al., Protein chips and nanomaterials for application in tumor marker immunoassays, Biosensors and Bioelectronics 2009;24:3399-411. Review of the role of nanomaterials in the diagnosis and understanding of cancer progression and etiology.
239. Cheng L, Yang K, Li Y, et al., Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy, Biomaterials 2012;33:2215-22. Experimental paper dealing with the preparation of upconversion nanoparticles and their application in multi-modal imaging.
240. Dastru W, Longo D, Silvio A, Contrast agents and mechanisms, Drug Discovery Today - Technologies 2011; 8:e109-115. Commentary on the status of contrast agents.
241. Dawson P, Functional imaging in CT, European Journal of Radiology 2006;60:331-40. The theoretical basis and applications of computed tomography.
242. Haase M, Schafer H, Upconverting nanoparticles, Angewandte Chemie International Edition 2011;50:5808-23. Review of the scientific basis of lanthanide-doped upconversion nanoparticles and their potential for medical imaging.
243. Hahn MA, Singh AK, Sharma P, Brown S C, Moudgil B M, Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives, Annals of Bioanalytical Chemistry 2011;27:3-27. Extensive review of the role of nanotechnology and nanoparticles in in vivo imaging methods.
244. Hasebrook K M, Serkova N J, Toxicity of MRI and Ct contrast agents, Expert Opinion on Drug Metabolism and Toxicity 2009;5:403-16. Discussion of the major adverse events that can be associated with the clinical use of contrast agents.
245. Kimmel D W, LeBlanc G, Meschievitz ME, Cliffel D E, Electrochemical sensors and biosensors, Analytical Chemistry 2012;84:685-707. Review of electrochemical and biochemical sensors, especially potentiometric, voltammetric and immunosensors.
246. Lee D-E, Koo H, Sun I-C, et al., Multifunctional nanoparticles for multimodal imaging and theranostics, Chemical Society Review 2012;41:2656-72. A tutorial review that highlights advances in the development of multifunctional nanoparticles for use in medicine.
247. Li L-L, Zhang R, Yin L, et al., Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes, Angewandte Chemie International Edition 2012; 51: 6121-5. Discussion of the surface coating of upconversion nanoparticles by phospholipids and other agents.
248. Li Y-F, Chen C, Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications, Small 2011;7:2965-80. Explanation of uptake, trafficking, pharmacokinetics and clearance of nanomaterials in biological systems.
249. Maurer-Jones MA, Bantz K C, Love S A, Marquis B J, Haynes C L, Toxicity of therapeutic nanoparticles, Nanomedicine 2009;4:219-41. A perspective on the toxicology of nanoparticle formulations in both therapy and imaging.
250. Na H B, Song I C, Hyeon T, Inorganic nanoparticles for MRI contrast agents, Advanced Materials 2009; 21;2133- 48. A review of the structure of contrast agents used in MRI.
251. Pimlott S L, Sutherland A, Molecular tracers for the PET and SPECT imaging of disease, Chemical Society Reviews 2011; 40:149-62. A chemically oriented tutorial review of the molecular probes used for positron emission tomography and single photon emission computed tomography, especially for imaging cancer and neurological disease.
252. Pysz MA, Gambhir S S, Willmann J K, Molecular imaging: current status and emerging strategies, Clinical Radiology 2010;65:500-16. Review of recent developments with molecular imaging and effects on clinical strategies.
253. Ronkainen NJ, Halsall HB, Heineman WR, Electrochemical biosensors, Chemical Society Reviews 2010;39:1747-63. A critical review of biocatalytic devices and affinity sensors.
254. Rosenthal S J, Chang J C, Kovtun O, McBride J R, Tomlinson I D, Biocompatible quantum dots for biological applications, Chemistry and Biology 2011;18:10-24. Tutorial style review of the biocompatibility of quantum dots.
255. Wadsak W, Mitterhauser M, Basics and principles of radiopharmaceuticals for PET/CT, European Journal of Radiology 2010;73:461-9. Brief review of the details of material specifications for radiopharmaceuticals.
256. Wang F, Banerjee D, Liu Y, Chen X, Liu X, Upconversion nanoparticles in biological labeling, imaging and therapy, Analyst 2010;135:1839-54. Review of optical biolabeling and imaging with upconversion nanoparticles.
257. Xie J, Lee S, Chen X, Nanoparticle-based theranostic agents, Advanced Drug Delivery Reviews 2010;62:1064-79. Review of the development of nanoparticles used in combined imaging and drug delivery processes.
258. Xing H, Bu W, Zhang S, et al., Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging, Biomaterials 2012;33:1079-89.
259. Zrazhevskiy P, Sena M, Gao X, Designing multifunctional quantum dots for bioimaging, detection, and drug delivery, Chemical Society Reviews 2010;39:4326-54. Critical review of the design principles governing the engineering of QD probes.
260. Balasubramanian S K, Yang L, Yung L-Y L, Ong C-N. Ong W-Y, Characterization, purification and stability of gold nanoparticles, Biomaterials 2010;31: 9023-30. Experimental demonstration of practical aspects of gold nanoparticle preparation and properties.
261. Brunette D M. Tengvall P, Textor M, Thomsen P (eds) Titanium in Medicine, Springer, Berlin, 2001. Comprehensive textbook on titanium.
262. Chaloupka K, Malam Y, Seifalian AM, Nanosilver as a new generation of nanoproduct in biomedical applications. Trends in Biotechnology 2010; 28:580-8. Review of the medical applications of silver nanoparticles.
263. Gu X, Zheng Y, Cheng Y, Zhong S, Xi T, In vitro corrosion and biocompatibility of binary magnesium alloys, Biomaterials 2009; 30:484-98. Review of experimental evidence on magnesium corrosion and tissue responses.
264. Levine B R, Sporer S, Poggie R A, Della Valle C J, Jacobs J J, Experimental and clinical performance of porous tantalum in orthopedic surgery, Biomaterials 2006; 27: 4671-81. Review of clinical evidence concerning porous tantalum.
265. Minoda Y, Kobayashi A, Iwaki H, et al., Comparison of bone mineral density between porous tantalum and cemented tibial total knee arthroplasty, Journal of Bone & Joint Surgery 2010; 92A: 700-6. Discusses advantages and disadvantages of porous metals in joint replacement.
266. Nguyen D T, Kim D-J, Kim K-S, Controlled synthesis and biomolecular probe application of gold nanoparticles, Micron 2011;42:207-27. Discusses the controlled synthesis of gold nanoparticles and demonstrates their application in the detection of proteins and nucleic acids.
267. Rondelli G, Torricelli P, Fini M, Giardino R, In vitro corrosion study by EIS of a nickel-free stainless steel for orthopedic applications, Biomaterials 2005;26:739-44. Experimental determination of the corrosion characteristics of nickel-free steels.
268. Shabalovskaya S, Rondelli G C, Undisz AL, et al., The electrochemical characteristics of Nitinol surfaces, Biomaterials 2009;30:3662-71. Discusses the effects of surface features on the chemical and biological properties of nickel-titanium.
269. Benzaid R, Chevalier J, Saadaoui M, et al. Fracture toughness, strength and slow crack growth in a ceria stabilized zirconia-alumina nanocomposite for medical applications, Biomaterials 2008;29:3636-41. Explanation of the mechanical properties of nanostructured zirconia-alumina ceramics.
270. Byers R J, Hitchman E R, Quantum dots brighten biological imaging, Progress in Histochemistry and Cytochemistry 2011; 45:201-37. Review of imaging possibilities with quantum dots.
271. Chevalier J, What future for zirconia as a biomaterial? Biomaterials 2006;27:535-43. Places the technology of transformation toughened zirconia in perspective.
272. Dorozhkin S V, Bioceramics of calcium orthophosphates, Biomaterials 2010;31:1465-85. Extensive review of medical uses of the main group of calcium phosphates.
273. Fuller J E, Zugates GT, Ferreira L S, et al., Intracellular delivery of core-shell fluorescent silica nanoparticles, Biomaterials 2008;29:1526-32. Discusses mechanisms of silica nanoparticle delivery to cells
274. Gabriel G, Erill I, Caro J, et al., Manufacturing and full characterization of silicon carbide-based multi-sensor micro-probes for biomedical applications, Microelectronics Journal 2007;38:406-15. Examines the feasibility of using silicon carbide substrates for multi-sensor micro-probes for monitoring organs during transplantation.
275. Hsieh C-L, Grange R, Psaltis, Bioconjugation of barium titanate nanocrystals with immunoglobulin G antibody for second harmonic radiation imaging probes, Biomaterials 2010;31:2272-7. Discusses conjugation of nanostructured barium titanate with amine groups and antibodies for imaging probes.
276. Liu X, Morra M, Carpi A, Li B, Bioactive calcium silicate ceramics and coatings, Biomedicine and Pharmacotherapy 2008;62:526-9. Brief practical details of calcium silicate coatings.
277. Thomas MV, Puleo D A, Calcium sulfate: properties and clinical applications, Journal of Biomedical Materials Research, Part B: Applied Biomaterials 2008; 88B:597-610. Review of properties, clinical applications and limitations of calcium sulfates.
278. Wang F, Banerjee D, Liu Y, Chen X, Liu X, Upconversion nanoparticles in biological labeling, imaging and therapy, Analyst 2010;135:1839-54. Review of optical bio-labeling and bio-imaging techniques using upconversion nanoparticles.
279. Weinstein J S, Varallyay C G, Dosa E, et al., Super paramagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies: a review, Journal of Cerebral Blood Flow & Metabolism 2010;30:15-35. Comprehensive review of the applications of iron oxide nanoparticles, especially in the central nervous system.
280. Wu C, Chang J, Synthesis and apatite-formation ability of akermanite, Materials Letters 2004;58:2415-17. Brief discussion of fabrication and biocompatibility of akermanite.
281. Ahmed TAE, Dare E V, Hincke M, Fibrin: a versatile scaffold for tissue engineering applications, Tissue Engineering Part B 2008;14(2):199-210. Reviews fibrin hydrogels, glues and scaffolds.
282. Allison D D, Grande-Allen K J, Hyaluronan: a powerful tissue engineering tool, Tissue Engineering 2006; 12:2131-40. Review of the tissue engineering potential for hyaluronan and the stimulation of the endogenous production of HA by cells.
283. Almine J F, Bax D V, Mithieux S M, et al., Elastin-based materials, Chemical Society Reviews 2010;39:3371- 9. Review of the physical and biological properties of elastin-based materials.
284. Altman GH, Diaz F, Jakuba C, et al., Silk-based biomaterials, Biomaterials 2003;24:401-16. Extensive discussion of the properties of silk-based biomaterials.
285. Badylak S F, Xenogeneic extracellular matrix as a scaffold for tissue reconstruction, Transplant Immunology 2004;12:367-77. Discussion of the principles of the ECM scaffold materials.
286. Batrakova WV, Kabanov AV, Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers, Journal of Controlled Release 2008; 130:98-106. Review of the biological response modifying activities of Pluronics and their application in nanomedicine.
287. Boland E D, Coleman B D, Barnes C P, et al., Electrospinning polydioxanone for biomedical applications, Acta Biomaterialia 2005;1:115-23. Discusses the electrospinning technology adapted for polydioxanone.
288. Bruggeman J P, de Bruin B-J, Bettinger C J, Langer R, Biodegradable poly(polol sebacate) polymers, Biomaterials 2008;29:4726-35. Describes development of biodegradable polymers based on structural units endogenous to human metabolism.
289. Caldorera-Moore M, Peppas N A, Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems, Advance Drug Delivery Reviews 2009;61:1391-1401. Reviews microscale and nanoscale environmentally responsive biomaterials for sensors and drug delivery.
290. Castro C I, Briceno J C, Perfluorocarbon-based oxygen carriers; review of products and trials, Artificial Organs 2010;34:622-34. Presentation of commercial products based on perfluorocarbon materials and their medical applications.
291. Chen G-Q, Wu Q, The application of polyhydroxyalkanoates as tissue engineering materials, Biomaterials 2005;26:6565-78. Extensive review of the PHB family of biodegradable polymers.
292. Crapo P M, Gilbert T W, Badylak S F, An overview of tissue and whole organ decellularization processes, Biomaterials 2011;32:3233-43. Extensive review of procedures and outcomes of different decellularization techniques.
293. Czaja W, Krystynowicz A, Bielecki S, Brown R M, Microbial cellulose - the natural power to heal wounds, Biomaterials 2006;27:145-51. Essay on the potential of bacterial cellulose.
294. Dimitrov I, Trzebicka B, Muller AHE, Dworal A, Tsvetanov C, Thermosensitive water-soluble copolymers with doubly responsive reversibly interacting entities, Progress in Polymer Science 2007;32:1275-43. Demonstration of amphiphilic water-soluble, multisensitive copolymer systems with thermoresponsive properties.
295. Dutta N K, Choudhury N R, Truong MY, Kim M, Elvin C M, Physical approaches for fabrication of organized nanostructure of resilin-mimetic elastic protein rec1-resilin. Biomaterials 2009; 30:4868-76. Practical aspects of resilin mimetic elastic proteins.
296. Falco E E, Patel M, Fisher J P, Recent developments in cyclic acetal biomaterials for tissue engineering, Pharmaceutical Research 2008;25:2348-56. Review of cyclic acetal polymers, polyacetals and polyketals.
297. Goda T, Ishihara K, Soft contact lens biomaterials from bioinspired phospholipid polymers, Expert Review of Medical Devices 2006;3:167-74. A discussion of the use of phospholipid polymers that enhance the biocompatibility and anti-fouling properties of soft contact lenses.
298. Gong S, Wang H, Sun Q, Xue S-T, Wang J-Y, Mechanical properties and in vitro biocompatibility of porous zein scaffolds, Biomaterials 2006;27:3793-9. Examination of the biocompatibility of porous zein scaffolds.
299. Gopferich A, Tessmar J, Polyanhydride degradation and erosion, Advanced Drug Delivery Reviews 2002;54:911-31. Reviews the major classes of anhydrides and the mechanisms of degradation and erosion of polyanhydrides.
300. Guimard N K, Gomez N, Schmidt C E, Conducting polymers in biomedical engineering, Progress in Polymer Science 2007; 32:876-921. Extensive review of the structure-property relationships in conducting polymers.
301. Hakkarainen M, Migration of monomeric and polymeric PVC plasticizers, Advances in Polymer Science 2008; 211:159-85. Discussion of DEHP plasticizer and polymeric alternatives.
302. Harris J M, Chess R B, Effect of pegylation on pharmaceuticals, Nature Reviews Drug Discovery 2003; 2:214-21. Review on the principles of regulation for drug delivery.
303. Heller J, Barr J, Ng S Y, Abdellauoi K S, Gurny R, Poly(ortho esters): synthesis, characterization, properties and uses, Advanced Drug Delivery Reviews 2002;54;1015-39. Review of history and optimization of poly(ortho esters).
304. Hill P, Brantley H, van Dyke M, Some properties of keratin biomaterials: Kerateines. Biomaterials 2010;31:585- 93. Discussion of experimentally determined biocompatibility properties of keratin-based biomaterials.
305. Ishihara K, Takai M, Bioinspired interface for nanobiodevices based on phospholipid polymer chemistry, Journal of the Royal Society Interface 2009;6:S279-91. Review of phospholipid surfaces on medical devices.
306. Iwasaki Y, Ishihara K, Phosphorylcholine-containing polymers for biomedical applications, Analytical and Bioanalytical Chemistry 2005;381:534-46. Review of the chemistry and biochemistry of phosphorylcholine-based polymers.
307. Khandare J, Mohr A, Calderon M, et al., Structure-biocompatibility relationship of dendritic derivatives, Biomaterials 2010;31:4268-77. Demonstrates that dendritic polyglycerols can be synthesized and used for delivery of therapeutic agents.
308. Kumar N, Langer R S, Domb AJ, Polyanhydrides: an overview, Advanced Drug Delivery Reviews 2002;54:889-910. Review of structure of the various polyanhydrides.
309. Kurtz S M, Devine J N, PEEK biomaterials in trauma, orthopedic and spinal implants, Biomaterials 2007;28:4845-69. Extensive review of materials science, biocompatibility and clinical applications of PEEK-based materials.
310. Lee H, Dellatore S M, Miller WM, Messersmith P B, Mussel-inspired surface chemistry for multi-functional coatings, Science 2007;318:426-30. Report of procedures to coat a variety of materials with surface-adherent polydopamine films that mimic the adhesive proteins found in mussels.
311. Lee J, Shanbhag S, Kotov NA, Inverted colloidal crystals as three-dimensional microenvironments for cellular co-culture. Journal of Material Chemistry 2006;16:3558-64. Discussion of the principles of inverted colloidal crystals.
312. Lee S, Yang S C, Heffernan MJ, Taylor WR, Murthy N, Polyketal microparticles: a new delivery vehicle for superoxide dismutase, Bioconjugate Chemistry 2007;18:4-7. Initial paper introducing polyketals for drug delivery.
313. Letellier P, Mayaffre A, Turmine M, Solubility of nanoparticles; nonextensive thermodynamics approach, Journal of Physics: Condensed Matter 2007; 19:4362-99. Analysis of thermodynamics of nanoparticle solubility characteristics; complex but good introduction
314. Martens P, Blundo J, Nilasaroya A, et al., Effect of poly (vinyl alcohol) macromer chemistry and chain interactions on hydrogel mechanical properties, Chemistry of Materials 2007;19:2641-8. Detailed analysis of poly(vinyl alcohol) and the structure- property relationships in hydrogels.
315. Martin D J, Poole Warren L A, et al., Polydimethylsiloxane/ polyether-mixed macrodiol-based polyurethane elastomers: biostability, Biomaterials 2000;21:1021- 9. Description of the synthetic chemistry underpinning the production of biostable polyurethanes using polydimethylsiloxane macrodiol.
316. Nguyen K F, West J L, Photopolymerizable hydrogels for tissue engineering applications, Biomaterials 2002;23:4307-14. Reviews the technology of photopolymerization of hydrogels.
317. Otsuka H, Nagasaki Y, Kataoka K, PEGylated nanoparticles for biological and pharmaceutical applications, Advanced Drug Delivery Reviews 2003;55:403-19. Discusses the principles of pegylation and medical uses.
318. Oudshoorn MHM, Rissmann R, Bouwstra J A, Hennink WE, Synthesis and characterization of hyperbranched polyglycerol hydrogels, Biomaterials 2006; 27:5471-9. Describes the polymer chemistry of polyglycerol hydrogels.
319. Pinchuk L, Wilson G J, Barry J J, et al., Medical applications of poly(styrene-block-isobutylene-block-stryrene) (“SIBS”), Biomaterials 2008;29:448-60. Thorough review of SIBS applications.
320. Qu X-H, Wu Q, Zhang K-Y, Chen G Q, In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers; biodegradation and tissue reactions, Biomaterials 2006;27:3540-8. Discusses experimental evidence of the degradation of PHBbased materials.
321. Rinaudo M, Main properties and current applications of some polysaccharides as biomaterials, Polymer International 2008;57:397-430. Extensive background to the applications of polysaccharides in medical technology.
322. Rubehn B, Stieglitz T, In vitro evaluation of the long term stability of polyimide as a material for neural implants, Biomaterials 2010;31:3449-58. Examination of the biocompatibility of polyimide neural electrodes.
323. Santerre J P, Woodhouse K, Laroche G, Labow R S, Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials, Biomaterials 2005;26:7457-70. Provides an analysis of the mechanisms of polyurethane degradation.
324. Sawant R R, Torchilin VP, Liposomes as “smart” pharmaceutical nanocarriers, Soft Matter 2010; 6: 4026-44. A thorough review of responsive liposomes.
325. Singh R S, Saina G K, Kennedy J F, Pullulan: microbial sources, production and applications, Carbohydrate Polymers 2008; 73:515-31. Critical appraisal of fungal exopolysaccharides including pullulan.
326. Sobieraj MC, Rimnac C M, Ultra high molecular weight polyethylene; mechanics, morphology and clinical behavior, Journal of the Mechanical Behavior of Biomedical Materials 2009; 2: 433-43. Detailed discussion of the mechanical properties of UHMW polyethylene.
327. Soon AS C, Stabenfeldt S E, Brown WE, Barker T H, Engineering fibrin matrices; the engagement of polymerization pockets through fibrin knob technology for the delivery and retention of therapeutic proteins, Biomaterials 2010;31:1944-54. Presents the technology for the therapeutic uses of engineered fibrin.
328. Tangpasuthadol V, Pendharkar P, Kohn J, Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part 1: Study on model compounds, Biomaterials 2000;21:2371-8. Discusses rationale for the development of biodegradable polycarbonate that has hydrolytically labile bonds in the repeating units of the polymer chain.
329. Tatai L, Moore T G, Adhikari R, et al., Thermoplastic biodegradable polyurethanes; the effect of chain extender structure on properties and in vitro degradation, Biomaterials 2007;28:5407-17. Experimental analysis of the role of molecular structure on the properties of degradable polyurethanes.
330. Teeri T T, Brumer H, Daniel G, Gatenholm P, Biomimetic engineering of cellulose-based materials, Trends in Biotechnology 2007;25:299-306. Overview of the structures of plant cell walls and approaches to mimic these cellulosic materials.
331. Torchilin VP, Micellar nanocarriers: pharmaceutical perspectives, Pharmaceutical Research 2007; 24:1-8. Reviews the structure of nanoscale micelles, micelleforming compounds and amphiphilic copolymers for drug delivery.
332. Vicennati P, Giuliano A, Ortaggi G, Masotti A, Polyethylenimine in medicinal chemistry, Current Medicinal Chemistry 2008;15:2826-39. Detailed discussion of the chemistry of PEI.
333. Wang Y, Ameer G A, Sheppard B J, Langer R, A tough biodegradable elastomer, Nature Biotechnology 2002;20:602-6. Explains the rationale and synthetic chemistry of poly(glycerol-sebacate).
334. Welle A, Kroger M, Doring M, et al., Electrospun aliphatic polycarbonates as tailored tissue scaffold materials, Biomaterials 2007;28:2211-19. Describes synthesis and electrospinning of aliphatic polycarbonates.
335. Yang C, Hillas P J, Baez J A, et al., The application of recombinant human collagen in tissue engineering, BioDrugs 2004;18:103-19. Discusses collagens and the prospects for making individual collagen types by recombinant technologies.
336. Zelzer M, Ulijn R V, Next generation peptide nanomaterials: molecular networks, interfaces and supramolecular functionality, Chemical Society Reviews 2010;39:3351-7. Analysis of the functionality of peptide nanomaterials.
337. Zhu J, Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering, Biomaterials 2010;31:4639-56. Detailed and informative review of PEG hydrogels.
338. Harrison B S, Atala A, Carbon nanotubes applications for tissue engineering, Biomaterials 2007; 28:344-53. Review of performance of carbon nanotubes and potential medical applications.
339. Hu W, Peng C, Luo W, et al., Graphene-based antibacterial paper. ACS Nano 2010;4:4317. Discussion of the antibacterial properties of graphene.
340. LaVan D A, Padera R F, Friedmann T A, et al., In vivo evaluation of tetrahedral amorphous carbon, Biomaterials 2005;26:465-73. Biocompatibility of tetrahedral amorphous carbon.
341. Markovic Z. Trajkovic V, Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60), Biomaterials 2008;29:3561-73. Mechanisms and biological consequences of ROS generation by fullerenes.
342. Roy R K, Lee K-R, Biomedical applications of diamond-like carbon coatings; a review. Journal of Biomedical Materials Research, Part B Applied Biomaterials 2007;83B:72-84. Discussion of the advantages and disadvantages of DLC materials and coatings.
343. Saito N, Aoki K, Shimizu M, et al., Application of carbon fibers to biomaterials: a new era of nano-level control of carbon fibers after 30 years of development, Chemical Society Reviews 2011;40:3824-34. Review of the history of carbon fiber applications to biomaterials and the role of carbon nanofibers in biomaterial composites.
344. Giacalone F, Martin N, Fullerene polymers; synthesis and properties, Chemical Reviews 2006; 106:5136-90. Detailed discussion of chemistry of fullerene polymers.
345. Grill A, Diamond-like carbon: state of the art, Diamond and Related Materials 1999; 8:428-34. Review of the structure and fabrication of DLC.
346. Crapo P M, Gilbert T W, Badylak S F, An overview of tissue and whole organ decellularization processes, Biomaterials 2011;32:3233-43. Review of principles and practical aspects of decellularization.
347. CSDH, Closing the Gap in a Generation: Health equity through action on the social determinants of health. Final report of the Commission on Social Determination of Health, World Health Organization, Geneva, 2008. Extensive analysis of the interplay between social and economic policy and health care.
348. Haihn R W, Klovers K B, Singer H J, The need for greater price transparency in the medical device industry: an economic analysis, Health Affairs 2008;27:1554-9. Discussion about medical device pricing and related economic issues.
349. International Standards Organization, Clinical Investigation of Medical Devices for Human Subjects - Good clinical practice, ISO 14155, 2011. Detailed standard for the conduct of human clinical trials on medical devices.
350. Karrholm J, The Swedish Hip Arthroplasty Register, Acta Orthopaedica 2010, 81, 3-4. A summary of the principles and workings of the first implant registry, established in Sweden in the 1970s.
351. Klepinski R J, Off-label use of medical devices in the USA, Journal of Medical Device Regulation 2009; 6:8-19. Essay about the pros and cons of the off-label use of medical devices.
352. Kramer D B, Xu, S, Kesselheim A S, Regulation of medical devices in the United States and Europe, New England Journal of Medicine 2012;336:845-55. Discussion of the similarities and differences between regulation in the USA and Europe.
353. Rizzieri, A G, Verheijde J L, Rady M Y, McGregor J L, Ethical challenges with the left ventricular assist device as a destination therapy, Philosophy, Ethics and Humanities in Medicine 2008; 3:20. A review of the value and difficulties of organ assist devices and the ethical issues that surround issues of quality of life for patients and care givers.
354. Superior Court of Justice, Ontario, Canada, Anderson v St Jude Medical Inc, 2012, ONSC 3660, Court File 00-CV-195906CV, Toronto, 26 June 2012. Written judgment on class action concerning silver-coated heart valves.
355. World Health Organization, Global Atlas on Cardiovascular Disease Prevention and Control, Mendis S, Puska P, Norrving B (eds.). Geneva, 2011. Detailed facts about the global incidence of cardiovascular disease.
356. Zacharias D G, Nelson T J, Mueller P S, Hook C C, The science and ethics of induced pluripotency: what will become of embryonic stem cells, Mayo Clinic Proceedings 2011; 86:634-40. Discussion of the debates that concern the ethical issues associated with the use of embryonic stem cells and iPS cells.